Metraipolis › archive › dc_68ef36bfa2f9
Clinical efficacy and mechanisms of hyperbaric oxygen therapy in the treatment of rheumatic and immune diseases — Europe PMC PMID:41488082
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41488082
- DOI
- 10.3389/fmed.2025.1706637
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T13:48:02.624Z
- SHA-256 of the archived text
bcb27e0e480b5047496ead58a5f5aa1365352518b8c0dc299340c6ff42fc5e18- Stable URL of this page
https://metraipolis.com/documento/dc_68ef36bfa2f9
How to cite
Clinical efficacy and mechanisms of hyperbaric oxygen therapy in the treatment of rheumatic and immune diseases — Europe PMC PMID:41488082 — Europe PMC (en), https://europepmc.org/article/MED/41488082 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68ef36bfa2f9 (Metraipolis archive dc_68ef36bfa2f9, sha256 bcb27e0e480b5047496ead58a5f5aa1365352518b8c0dc299340c6ff42fc5e18)
BibTeX
@misc{dc68ef36bfa2f9,
title = {Clinical efficacy and mechanisms of hyperbaric oxygen therapy in the treatment of rheumatic and immune diseases — Europe PMC PMID:41488082},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41488082},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68ef36bfa2f9; sha256 bcb27e0e480b5047496ead58a5f5aa1365352518b8c0dc299340c6ff42fc5e18},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488082. Agents can read the archived copy with the MCP tool read_document.